ATOS - Company ID 0001488039
ATOSSA THERAPEUTICS, INC. trades as ATOS. This page tracks ATOSSA THERAPEUTICS, INC. through 634 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Over the last 4 fiscal years ATOSSA THERAPEUTICS, INC.'s revenue grew from $1.50K to $1.76K, a compound annual growth rate of 4.0%.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Major company event | 8-K | 2026-05-08 |
| Quarterly report | 10-Q | 2026-05-08 |
The largest companies sharing ATOSSA THERAPEUTICS, INC.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year ATOSSA THERAPEUTICS, INC. reported a net loss of $34.77M.